Cholera outbreak in South Africa, 2008-2009: Laboratory analysis of Vibrio cholerae O1 strains

Journal of Infectious Diseases

Volumn 208, Issue SUPPL. 1, 2013, Pages

  Ismail, Husna ^a,b   Smith, Anthony M ^a,b   Tau, Nomsa P ^a,b   Sooka, Arvinda ^a   Keddy, Karen H ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

cholera outbreak; classical cholera toxin; multidrug resistant; South Africa; SXT element; TEM 63 lactamase; Vibrio cholerae O1 El Tor variant

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CHOLERA TOXIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; NALIDIXIC ACID; PROTEIN PARC; SERINE; TETRACYCLINE;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BASE PAIRING; CHOLERA; CONTROLLED STUDY; CTXA GENE; CTXAB GENE; ENZYME ACTIVITY; EPIDEMIC; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; LABORATORY TEST; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SOUTH AFRICA; TCPA GENE; VIBRIO CHOLERAE;

CHOLERA OUTBREAK; CLASSICAL CHOLERA TOXIN; MULTIDRUG-RESISTANT; SOUTH AFRICA; SXT ELEMENT; TEM-63 Β-LACTAMASE; VIBRIO CHOLERAE O1 EL TOR VARIANT;

ANTI-BACTERIAL AGENTS; CHOLERA; DISEASE OUTBREAKS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MUTATION; SEROTYPING; SOUTH AFRICA; VIBRIO CHOLERAE O1; VIRULENCE;

EID: 84885777479     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit200     Document Type: Article

References (44)

1. Tran HD, Alam M, Trung NV, et al. Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010. J Med Microbiol 2012; 61:431-7.
2. Ali M, Emch M, Park JK, Yunus M, Clemens J. Natural cholera infection-derived immunity in an endemic setting. J Infect Dis 2011; 204:912-8.
3. Charles RC, Ryan ET. Cholera in the 21st century. Curr Opin Infect Dis 2011; 24:472-7.
4. Boore A, Iwamoto M, Mintz E, Yu E, Chaignat C. Cholera and other Vibrioses. In: Heymann DL, ed. Control of communicable diseases manual. 19th ed. Baltimore: United Book Press Inc., 2008:120-9.
5. Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 2011; 477:462-5.
6. Lee K. The global dimensions of cholera. Global Change and Human Health 2001; 2:6-17.
7. Safa A, Nair GB, Kong RY. Evolution of new variants of Vibrio cholerae O1. Trends Microbiol 2010; 18:46-54.
8. Talkington D, Bopp C, Tarr C, et al. Characterization of toxigenic Vibrio cholerae from Haiti, 2010-2011. Emerg Infect Dis 2011; 17: 2122-9.
9. Dowell SF, Braden CR. Implications of the introduction of cholera to Haiti. Emerg Infect Dis 2011; 17:1299-300.
10. Mukandavire Z, Liao S, Wang J, Gaff H, Smith DL, Morris JG Jr. Estimating the reproductive numbers for the 2008-2009 cholera outbreaks in Zimbabwe. Proc Natl Acad Sci USA 2011; 108:8767-72.
11. Islam MS, Mahmud ZH, Ansaruzzaman M, et al. Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe. J Clin Microbiol 2011; 49:2325-7.
12. Mintz ED, Guerrant RL. A lion in our village-the unconscionable tragedy of cholera in Africa. N Engl J Med 2009; 360:1060-3.
13. National Institute for Communicable Disease Bulletin. Cholera outbreak in South Africa: preliminary descriptive epidemiology on laboratoryconfirmed cases, 15 November 2008 to April 2009. http://www.nicd.ac. za/assets/files/ CommDisBullMay09-Vol0702.pdf. Accessed 03 September 2012.
14. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-18. Wayne, PA: Clinical and Laboratory Standards Institute. 2008; 28.
15. Ng LK, Sawatzky P, Galas M, et al. Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin? Antimicrob Agents Chemother 2003; 47:1479-80. (Pubitemid 36368626)
16. Cooper KL, Luey CK, Bird M, et al. Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae. Foodborne Pathog Dis 2006; 3:51-8.
17. Hunter SB, Vauterin P, Lambert-Fair MA, et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005; 43:1045-50. (Pubitemid 40364915)
18. Keasler SP, Hall RH. Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 1993; 341:1661. (Pubitemid 23175273)
19. Ismail H, Smith AM, Sooka A, Keddy KH. Genetic characterization of multidrug-resistant, extended-spectrum ?-lactamase-producing Vibrio cholerae O1 outbreak strains, Mpumalanga, South Africa, 2008. J Clin Microbiol 2011; 49:2976-9.
20. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145:1365-73. (Pubitemid 11097357)
21. Mandomando I, Espasa M, Valles X, et al. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhica District Hospital, southern Mozambique. J Antimicrob Chemother 2007; 60:662-4. (Pubitemid 47299886)
22. Opintan JA, Newman MJ, Nsiah-Poodoh OA, Okeke IN. Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element. J Antimicrob Chemother 2008; 62:929-33.
23. du Preez M, van der Merwe MR, Cumbana A, le Roux W. A survey of Vibrio cholerae O1 and O139 in estuarine waters and sediments of Beira, Mozambique.Water SA 2010; 36:615-20.
24. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-81.
25. Kingston JJ, Thavachelvam K, Tuteja U, James T, Janardhanan B, Batra HV. Antimicrobial suscetibility and molecular characterization of Vibrio cholerae from cholera outbreaks in Chennai. Indian J Microbiol 2009; 49:84-8.
26. Mandal J, Sangeetha V, Ganesan V, et al. Third-generation cephalosporin-resistant Vibrio cholerae, India. Emerg Infect Dis 2012; 18:1326-8.
27. Usha G, Chunderika M, Prashini M, Willem SA, Yusuf ES. Characterization of extended-spectrum beta-lactamases in Salmonella spp. at a tertiary hospital in Durban, South Africa. Diagn Microbiol Infect Dis 2008; 62:86-91.
28. Essack SY, Hall LM, Pillay DG, McFadyen ML, Livermore DM. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother 2001; 45:88-95. (Pubitemid 32039099)
29. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11:355-62.
30. Petroni A, Corso A, Melano R, et al. Plasmidic extended-spectrum ?-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. Antimicrob Agents Chemother 2002; 46:1462-8. (Pubitemid 34415329)
31. Dalsgaard A, Forslund A, Sandvang D, Arntzen L, Keddy K. Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. J Antimicrob Chemother 2001; 48:827-38. (Pubitemid 33735319)
32. Ceccarelli D, Salvia AM, Sami J, Cappuccinelli P, Colombo MM. New cluster of plasmid-located Class 1 integrons in Vibrio cholerae O1 and a dfrA15 cassette-containing integron in Vibrio parahaemolyticus isolated in Angola. Antimicrob Agents Chemother 2006; 50:2493-9. (Pubitemid 43993191)
33. Ceccarelli D, Bani S, Cappuccinelli P, Colombo MM. Prevalence of aadA1 and dfrA15 class 1 integron cassettes and SXT circulation in Vibrio cholerae O1 isolates from Africa. J Antimicrob Chemother 2006; 58:1095-7.
34. Okoh A, Igbinosa E. Antibiotic susceptibility profiles of some Vibrio strains isolated from wastewater final effluents in a rural community of the Eastern Cape Province of South Africa. BMC Microbiol 2010; 10:143.
35. Hochhut B, Lotfi Y, Mazel D, Faruque SM, Woodgate R, Waldor MK. Molecular analysis of the antibiotic resistance gene clusters in the Vibrio cholerae O139 and O1 SXT constins. Antimicrob Agents Chemother 2001; 45:2991-3000. (Pubitemid 32988819)
36. Kim HB,Wang M, Ahmed S, et al. Transferable quinolone resistance in Vibrio cholerae. Antimicrob Agents Chemother 2010; 54:799-803.
37. Baranwal S, Dey K, Ramamurthy T, Nair GB, Kundu M. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother 2002; 46:2676-8. (Pubitemid 34793486)
38. da Fonseca EL, Vicente AC. Spread of the qnrVC quinolone resistance determinant in Vibrio cholerae. Antimicrob Agents Chemother 2011; 55:457.
39. Etinosa O, Igbinosa EO, Okoh AI. Toxigenic Vibrio cholerae strains and their associated malaises. African J Med Res 2009; 3:200-11.
40. Smith AM, Keddy KH, Ismail H, et al. Possible laboratory contamination leads to incorrect reporting of Vibrio cholerae O1 and initiates an outbreak response. J Clin Microbiol 2011; 50:480-2.
41. Quilici ML, Massenet D, Gake B, Bwalki B, Olson DM. Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa. Emerg Infect Dis 2010; 16:1804-5.
42. Ansaruzzaman M, Bhuiyan NA, Nair BG, et al. Cholera in Mozambique, variant of Vibrio cholerae. Emerg Infect Dis 2004; 10:2057-9. (Pubitemid 39458582)
43. Halder K, Das B, Nair GB, Bhadra RK. Molecular evidence favouring step-wise evolution of Mozambique Vibrio cholerae O1 El Tor hybrid strain. Microbiology 2010; 156:99-107.
44. Reimer AR, Van DG, Stroika S, et al. Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa. Emerg Infect Dis 2011; 17: 2113-21.